Single User License: $5000
Member Price: FREE
Use code SUMMER at checkout for 50% OFF
Already a member? Login to access this report free.
Report Highlights
With BCC Research's Bitopertin® Forecast, you will have quantitative data about forecasted revenue for the pharmaceutical drug bitopertin®, currently in development, that will guide you in your strategic decision-making regarding future participation in this product sector.
The BCC Research Bitopertin® Forecast is a quantitative forecast model in an easily accessible Microsoft® Excel® spreadsheet, segmented by specific parameters. It features:
• Market demand forecasts for Bitopertin® annually for the years 2016 to 2030 by volume (number of patients) and value (in U.S. dollars), should the drug be licensed
• Segmentation of volume and value for these regions:
• United States
• Japan
• France
• Germany
• Italy
• Spain
• United Kingdom
• Data transparency and sources disclosed for:
• Patient volumes, with forecasts by age range and prevalence, as well as population estimates
• Product pricing forecasts
Use the BCC Research Bitopertin® Forecast to:
• Examine forecasted market demand for Bitopertin®
• Validate other Bitopertin® market-demand data to which you have access
• Make strategic decisions about entering Bitopertin®-related or schizophrenia treatment-related markets
Bitopertin® is a drug under development intended to be used in combination with antipsychotic medications for the treatment of persistent negative symptoms or sub-optimally controlled positive symptoms associated with schizophrenia.
Figure 1 Summary Graphs - Value in U.S.D. and Patient Volumes, by Region, 2016-2030
Table 1 Total Market - Value in U.S.D. and Patient Volumes, by Region, 2016-2030
Table 2 United States Patient Volumes, 2010-2030
Table 3 Japan Patient Volumes, 2010-2030
Table 4 France Patient Volumes, 2010-2030
Table 5 Germany Patient Volumes, 2010-2030
Table 6 Italy Volumes, 2010-2030
Table 7 Spain Patient Volumes, 2010-2030
Table 8 UK Patient Volumes, 2010-2030
Table 9 United States Population by age range, 2010-2012; and 2015 to 2060
Table 10 Europe Population by Country, 2010-2030
Table 11 Japan Population, 2010-2030
Table 12 US Pricing and FX Rate, 2016-2030
Table 13 Japan Pricing and FX rate, 2016-2030
Table 14 France Pricing and FX rate, 2016-2030
Table 15 Germany Pricing and FX rate, 2016-2030
Table 16 Italy Pricing and FX rate, 2016-2030
Table 17 Spain Pricing and FX rate, 2016-2030
Table 18 UK Pricing and FX rate, 2016-2030
Analyst Credentials
Jackson Highsmith is a life sciences research consultant with more than 16 years of research experience. Jackson has been consulting with specialty pharmaceuticals and large pharmaceutical industry players since 2007. Prior to that, he worked at a large research consultancy, where he focused on in-depth research; he also has worked at a large pharmaceutical company in a wide range of medical therapeutics in early- and mid-stage drug development. Jackson Highsmith is a pseudonym of the author.
Related Reports
Recent Reports
BCC Research Bitopertin® Forecast
With BCC Research's Bitopertin® Forecast, you will have quantitative data about forecasted revenue for the pharmaceutical drug bitopertin®, currently in development, that will guide you in your strategic decision-making regarding future participation in this product sector. The BCC Research Bitopertin® Forecast is a quantitative forecast model in an easily accessible Microsoft® Excel® spreadsheet, segmented by specific parameters. It features:• Market demand forecasts for Bitopertin® annually for the years 2016 to 2030 by volume (number of patients) and value (in U.S. dollars), should the drug be licensed• Segmentation of volume and value for these regions: • United States • Japan • France • Germany • Italy • Spain • United Kingdom• Data transparency and sources disclosed for: • Patient volumes, with forecasts by age range and prevalence, as well as population estimates • Product pricing forecastsUse the BCC Research Bitopertin® Forecast to:• Examine forecasted market demand for Bitopertin® • Validate other Bitopertin® market-demand data to which you have access• Make strategic decisions about entering Bitopertin®-related or schizophrenia treatment-related marketsBitopertin® is a drug under development intended to be used in combination with antipsychotic medications for the treatment of persistent negative symptoms or sub-optimally controlled positive symptoms associated with schizophrenia.
BCC Research Strattera ® Forecast
BCC Research is pleased to announce the BCC Research Strattera ® Forecast , a strategic investment product designed to provide market data for the pharmaceutical drug Strattera ®, a treatment for Attention Deficit Hyperactivity Disorder (ADHD) distributed by Eli Lilly and Company. Strattera ® will lose its branded patent protection in late 2016 going into 2017, opening the market to distribution of generic treatments by competing companies.
Top Trending Reports
Life Science Tools and Reagents: Global Markets
The global market for life science tools and reagents, including COVID-19 diagnostics was valued at $59.4 billion in 2023. This market is expected to grow from $53.2 billion in 2024 to reach $66.5 billion by the end of 2029, at a CAGR of 4.6% during the forecast period of 2024-2029.
Wearable Medical Devices: Technologies and Global Markets
The global market for wearable medical devices was valued at $35.6 billion in 2023. This market is estimated to grow from $45.0 billion in 2024 to $151.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.5% from 2024 through 2029.
Carbon Credits Market: Global Outlook
This report provides an up-to-date analysis of current and future markets for carbon credits and the carbon offsets industry. It presents a thorough and up-to-date global assessment of the market and business of carbon credits. The report also includes a competitive landscape, ESG analysis, and detailed company profiles of leading market players.
Biodegradable Polymers: Global Markets and Technologies
The global market volumes of biodegradable polymers is expected to grow from 1,286.0 kilotons in 2023 and is projected to reach 4,140.0 kilotons by the end of 2028, at a compound annual growth rate (CAGR) of 26.3% during the forecast period of 2023 to 2028.
Radiotherapy, Radiopharmaceuticals and Nuclear Medicine: Global Markets
The global market for radiation therapy products and radiopharmaceuticals is expected to grow from $17.5 billion in 2024 and is projected to reach $31.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 12.3% during the forecast period of 2024 to 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More